nocodazole has been researched along with Experimental Mammary Neoplasms in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We show in this report that treatment of only M phase-arrested mouse cells, with the protein kinase inhibitor staurosporine, induced polyploidy." | 7.69 | A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. ( Bradbury, EM; Guo, XW; Hall, LL; Teplitz, RL; Th'ng, JP, 1996) |
| " We show in this report that treatment of only M phase-arrested mouse cells, with the protein kinase inhibitor staurosporine, induced polyploidy." | 3.69 | A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. ( Bradbury, EM; Guo, XW; Hall, LL; Teplitz, RL; Th'ng, JP, 1996) |
| "Paclitaxel is a potent anti-tumor drug used in the treatment of breast cancer." | 1.30 | Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: enhancement by paclitaxel and inhibition by nocodazole. ( Alonso, DF; Aon, MA; Arregui, C; Farina, HG; Gomez, DE, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roos, E | 1 |
| Van de Pavert, IV | 1 |
| Segall, JE | 1 |
| Tyerech, S | 1 |
| Boselli, L | 1 |
| Masseling, S | 1 |
| Helft, J | 1 |
| Chan, A | 1 |
| Jones, J | 1 |
| Condeelis, J | 1 |
| Hall, LL | 1 |
| Th'ng, JP | 1 |
| Guo, XW | 1 |
| Teplitz, RL | 1 |
| Bradbury, EM | 1 |
| Alonso, DF | 1 |
| Farina, HG | 1 |
| Arregui, C | 1 |
| Aon, MA | 1 |
| Gomez, DE | 1 |
| Liu, Q | 1 |
| Guntuku, S | 1 |
| Cui, XS | 1 |
| Matsuoka, S | 1 |
| Cortez, D | 1 |
| Tamai, K | 1 |
| Luo, G | 1 |
| Carattini-Rivera, S | 1 |
| DeMayo, F | 1 |
| Bradley, A | 1 |
| Donehower, LA | 1 |
| Elledge, SJ | 1 |
5 other studies available for nocodazole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Effect of tubulin-binding agents on the infiltration of tumour cells into primary hepatocyte cultures.
Topics: Animals; Benzimidazoles; Carbamates; Cell Adhesion; Cell Communication; Cells, Cultured; Colchicine; | 1982 |
EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.
Topics: Actins; Adenocarcinoma; Animals; Cell Movement; Chemotaxis; Cytochalasin D; Dose-Response Relationsh | 1996 |
A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation.
Topics: Alkaloids; Animals; Antineoplastic Agents; CDC2 Protein Kinase; DNA, Neoplasm; Enzyme Inhibitors; G1 | 1996 |
Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: enhancement by paclitaxel and inhibition by nocodazole.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Collagenases; Mammary Neoplasms, | 1999 |
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
Topics: Alleles; Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cyc | 2000 |